Dr. David Porter, MD
Claim this profileUniversity of Pennsylvania
Affiliated Hospitals
University Of Pennsylvania
University Of Pennsylvania/Abramson Cancer Center
Clinical Trials David Porter, MD is currently running
DSG3-CAART Cell Therapy
for Pemphigus Vulgaris
This trial is testing new cell therapies for patients with pemphigus vulgaris who don't respond to standard treatments. The therapies involve modifying the patient's own immune cells to better fight the disease and potentially provide long-term relief.
Recruiting
1 award
Phase 1 & 2
4 criteria
Tadekinig Alfa
for Cytokine Release Syndrome
This is a pilot, open-label study to assess the safety and feasibility of using investigational drug(s) as rescue therapies for CAR T cell related CRS and HLH-like syndrome (CRHLS).
Recruiting
1 award
Phase < 1
More about David Porter, MD
Clinical Trial Related
5 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments David Porter, MD has experience with
- Natalizumab
- Steroids
- DSG3-CAART
- Tadekinig Alfa (IL-18BP)
Breakdown of trials David Porter, MD has run
Acute Graft-versus-Host Disease
Graft-versus-Host Disease
Nail Conditions
Subcorneal Pustular Dermatosis
Immune Dysfunction
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Porter, MD specialize in?
David Porter, MD focuses on Acute Graft-versus-Host Disease and Graft-versus-Host Disease. In particular, much of their work with Acute Graft-versus-Host Disease has involved treating patients, or patients who are undergoing treatment.
Is David Porter, MD currently recruiting for clinical trials?
Yes, David Porter, MD is currently recruiting for 2 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that David Porter, MD has studied deeply?
Yes, David Porter, MD has studied treatments such as Natalizumab, Steroids, DSG3-CAART.
What is the best way to schedule an appointment with David Porter, MD?
Apply for one of the trials that David Porter, MD is conducting.
What is the office address of David Porter, MD?
The office of David Porter, MD is located at: University of Pennsylvania, Philadelphia, Pennsylvania 19104 United States. This is the address for their practice at the University of Pennsylvania.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.